Related Experiment Video
Updated: Oct 2, 2025
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Brain Damage in the Preterm Infant: Clinical Aspects and Recent Progress in the Prevention and Treatment
Yixuan Xie1, Yue Yang1, Tianming Yuan1
1Department of Neonatology, Children\'s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052, Zhejiang, P.R. China.
Insights
Preventing brain injury in preterm infants remains a challenge, with subtle lesions impacting neurodevelopment. Research explores drugs like erythropoietin and mesenchymal stem cells, but effectiveness requires further study.
Area of Science:
- Neonatal neurology
- Neurodevelopmental disabilities
- Public health
Background:
- Preterm birth poses significant risks for brain injury and neurodevelopmental disabilities.
- Current clinical focus is on prevention due to the lack of effective treatments for established premature infant brain injury.
- Understanding the impact of neonatal treatments on cerebral hemodynamics is crucial for injury prevention.
Approach:
- This review synthesizes findings from preclinical studies on etiological pathways.
- It provides an update on the latest research regarding prevention and treatment strategies.
- The review examines the evidence for drugs such as erythropoietin, melatonin, and mesenchymal stem cells.
Key Points:
- The pattern of brain injury in preterm infants has shifted towards more subtle lesions.
- Diagnosing these subtle lesions is critical for predicting neurodevelopmental outcomes.
- Gaps in understanding neonatal interventions' effects on brain injury persist.
Conclusions:
- No definitive neuroprotective strategies currently exist for preterm infant brain injury.
- While some drugs show promise, research quality and therapeutic effectiveness remain debated.
- Further investigation into pathogenesis and treatment efficacy is essential.
Abstract:
Although the prevalence of brain injury and related neurodevelopmental disabilities resulting from preterm birth are major public health concerns, there are no definite neuroprotective strategies to prevent or reduce brain injury. The pattern of brain injury seen in preterm infants has evolved into more subtle lesions that are still essential to diagnose regarding neurodevelopmental outcomes. There is no specific effective method for the treatment of premature infant brain injury, and the focus of clinical treatment is still on prevention. Prevention of this injury requires insight into the pathogenesis, but many gaps exist in our understanding of how neonatal treatment procedures and medications impact cerebral hemodynamics and preterm brain injury. Many studies provide evidence about the prevention of premature infant brain injury, which is related to some drugs (such as erythropoietin, melatonin, mesenchymal stem cells, etc.). However, there are still some controversies about the quality of research and the effectiveness of therapy. This review aims to recapitulate the results of preclinical studies and provide an update on the latest developments around etiological pathways, prevention, and treatment.
More Related Videos
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
07:57Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022